Literature DB >> 9329569

Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance.

G Gebauer1, W Müller-Ruchholtz.   

Abstract

Tumor markers CEA, CA19-9, CA15-3, CA125, AFP, beta-HCG, SCC were measured quantitatively in the serum, tumor tissue and healthy colonic mucosa of patients with colorectal cancer. We wanted to investigated whether there is a difference in concentration between patients with and without recurrence of cancer. During the follow-up period 14 of 38 patients showed tumor recurrence. The patients with cancer relapse had higher preoperative serum levels of CEA and CA19-9 and in the histologically normal colonic mucosa they had higher concentrations of CEA, CA19-9, SCC and low CA15-3. The highest values of CEA, CA19-9, and SCC occurred in the mucosa of patients developing local cancer recurrence. Marker concentrations in tumor tissues themselves did not differ between patients with or without tumor relapse. Though confirmation in a larger number of cases is needed we conclude from these results that tumor marker concentrations in the healthy colonic mucosa of patients with colorectal cancer may become valuable indicators of the risk of tumor recurrence.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9329569

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

Review 1.  Cell surface molecules and their prognostic values in assessing colorectal carcinomas.

Authors:  J Haier; M Nasralla; G L Nicolson
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

2.  Human cervical cancer oncogene-1 over expression in colon cancer and its clinical significance.

Authors:  Kai Meng; Min Yuan; Shujian Xu; Lifeng Wang; Zhe Li; Mingyu Wang; Rong Ma
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 3.  Primary and metastatic peritoneal surface malignancies.

Authors:  Delia Cortés-Guiral; Martin Hübner; Mohammad Alyami; Aditi Bhatt; Wim Ceelen; Olivier Glehen; Florian Lordick; Robert Ramsay; Olivia Sgarbura; Kurt Van Der Speeten; Kiran K Turaga; Manish Chand
Journal:  Nat Rev Dis Primers       Date:  2021-12-16       Impact factor: 52.329

Review 4.  Characterization of disease-associated N-linked glycoproteins.

Authors:  Yuan Tian; Hui Zhang
Journal:  Proteomics       Date:  2013-02       Impact factor: 3.984

Review 5.  Characterization of Pharmaceutical IgG and Biosimilars Using Miniaturized Platforms and LC-MS/MS.

Authors:  Kerry M Wooding; Wenjing Peng; Yehia Mechref
Journal:  Curr Pharm Biotechnol       Date:  2016       Impact factor: 2.837

6.  Study on specificity of colon carcinoma-associated serum markers and establishment of SVM prediction model.

Authors:  Lu Li; Xuhui Ma
Journal:  Saudi J Biol Sci       Date:  2017-01-26       Impact factor: 4.219

Review 7.  Nanotechnologies in glycoproteomics.

Authors:  Hu Zhao; Yaojun Li; Ye Hu
Journal:  Clin Proteomics       Date:  2014-05-13       Impact factor: 3.988

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.